Spatial Genomics and Transcriptomics Market by Technique, Product Type, Application, and End User : Global Opportunity Analysis and Industry Forecast, 2021–2030

Spatial Genomics and Transcriptomics Market by Technique, Product Type, Application, and End User : Global Opportunity Analysis and Industry Forecast, 2021–2030

  • February 2022 •
  • 311 pages •
  • Report ID: 6269573 •
  • Format: PDF
Spatial Genomics and Transcriptomics Market by Technique (Spatial Transcriptomics, and Spatial Genomics Analysis), Product Type (Instruments, Consumables, and Software), Application, (Translational Research, and Drug Discovery & Development) and End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Academic & Research Institutes): Global Opportunity Analysis and Industry Forecast, 2021–2030


The global spatial genomics and transcriptomics market was valued at $626.9 million in 2020 and is projected to reach $2,159.61 million by 2030, registering a CAGR of 13.6% from 2021 to 2030.
The studies of all genes and their associated mRNAs are correspondingly called genomics and transcriptomics. It is a method usually designed to assign cell types (mainly identified by mRNA readouts) to their locations in histological sections. This method can also be used to determine subcellular localization of mRNA molecules and their cellular heterogeneity in tissues, and tumors. In addition, spatial genomics and transcriptomics also provides information regarding immune cells as well as determine subcellular distribution of transcripts in various conditions.
Spatial genomics has tremendous potential in disease control as it helps to provide quantitative gene expression results, coupled with DNA & RNA visualization mapping within tissue parts. In spatial transcriptomics, sequencing techniques have a major share due to wide availability of sequencing platforms that help study RNA architecture in tissues or cells and use of advanced techniques within a laboratory setup to study biological organisms, which needs trained experts such as researchers and technicians. Genomics provides an overview of the complete set of genetic instructions provided by the DNA, while transcriptomics looks into gene expression patterns. The main driving factor that drives growth of the spatial genomics and transcriptomics market include, increase in adoption of spatial genomics and transcriptomics owing to its various application.
In addition, rise in prevalence of genetic disorders and applications of spatial genomics and transcriptomics in determination of disease and treatment markers, further supplement the global spatial genomics and transcriptomics market growth. Furthermore, growing preference toward personalized medicines also fuels growth of the market.
Conversely, unavailability of skilled professionals and ethical & legal limitations associated with the use of spatial genomics and transcriptomics technologies are expected to obstruct the growth of the market during forecast years. On the other hand, growth in innovations in spatial genomics and transcriptomics technologies are expected to offer profitable opportunities for the growth of the market during the forecast period.
The global spatial genomics and transcriptomics market is segmented on the basis of technique, product type, application, end user and region to provide a detailed assessment of the market. By technique, it is bifurcated into spatial transcriptomics, and spatial genomics analysis. The spatial transcriptomics is segmented into microdissection, fluorescent in-situ hybridization, in-situ sequencing, in-situ capturing, and in-silico construction.
In addition, the spatial genomics analysis is segmented into, fluorescence in-situ sequencing, and fluorescence microscopy. By product type, it is segmented into instruments, consumables, and software. By application, it is divided into, translational research, and drug discovery & development. Based on end user, it is segmented into pharmaceutical & biotechnology companies, contract research organizations, and academic & research institutes. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key market players profiled in the report include 10X Genomics, Inc., Akoya Biosciences, Inc., BioSpyder Technologies Inc., Bio-Techne Corporation (Advanced Cell Diagnostics, Inc.), Dovetail Genomics, LLC, Fluidigm Corporation, Genomic Vision SA, Illumina, Inc., Lunaphore Technologies SA, Nanostring Technologies, Inc., Natera Inc., PerkinElmer Inc. (Horizon Discovery Group Plc), Rarecyte, Inc., Rebus Biosystems, LLC, Resolve Biosciences, S2 Genomic, Seven Bridges Genomics, Singular Genomics System, Inc., Tecan Group Ltd. (Nugen Technologies, Inc.), Ultivue, Inc., Veranome Biosystems LLC, and Vizgen Corporation.

KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the global spatial genomics and transcriptomics market along with the current trends and future estimations to elucidate the imminent investment pockets.
• A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
• Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
• Extensive analysis of the key segments of the industry helps to understand the application and products of spatial genomics and transcriptomics used across the globe.
• Key market players and their strategies have been analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS
- By Technique
- Spatial Transcriptomics
- Microdissection
- Fluorescent In-situ hybridization
- In-situ sequencing
- In-situ capturing
- In-silico construction
- Spatial Genomics Analysis
- Fluorescence In-situ sequencing
- Fluorescence Microscopy

- By Product Type
- Instruments
- Consumables
- Software

- By Application
- Translational Research
- Drug Discovery & Development

- By End User
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Academic & Research Institutes

- By Region
- North America
- U.S.
- Canada
- Mexico

- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe

- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific

- LAMEA
- Latin America
- Middle East and Africa

LIST OF KEY PLAYERS PROFILED IN THE REPORT
• 10X Genomics, Inc.
• Akoya Biosciences, Inc.
• BioSpyder Technologies Inc.
• Bio-Techne Corporation (Advanced Cell Diagnostics, Inc.)
• Dovetail Genomics, LLC
• Fluidigm Corporation
• Genomic Vision SA
• Illumina, Inc.
• Lunaphore Technologies SA
• Nanostring Technologies, Inc.
• Natera Inc.
• PerkinElmer Inc. (Horizon Discovery Group Plc)
• Rarecyte, Inc.
• Rebus Biosystems, LLC
• Resolve Biosciences
• S2 Genomic
• Seven Bridges Genomics
• Singular Genomics System, Inc.
• Tecan Group Ltd. (Nugen Technologies, Inc.)
• Ultivue, Inc.
• Veranome Biosystems LLC
• Vizgen Corporation